MedTrace Logo

Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing

NCT05959954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-07-25

No results posted yet for this study

Summary

This study aims to investigate the predictive value of quantitative sensory testing (QST) in identifying patients with carpal tunnel syndrome (CTS) who are at risk of developing nociplastic pain.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DIAGNOSTIC_TEST

Quantitative Sensory Testing (QST)

Quantitative Sensory Testing (QST) is a non-invasive diagnostic method used to assess sensory dysfunction. The test evaluates individual thresholds and pain responses to different types of mechanical, thermal, and electrical stimuli. For this study, QST will be used to gather baseline sensory data for patients with carpal tunnel syndrome. This information will then be used to predict the progression to nociplastic pain over a one-year follow-up period.

Sponsors & Collaborators

  • Ahram Canadian University

    lead OTHER

Principal Investigators

  • Amal Fawzy, Ph.d · Faculty of Physical Therapy, Ahram Canadian University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-21
Primary Completion
2024-07-21
Completion
2024-11-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959954 on ClinicalTrials.gov